HAUSMAN DIANA 4
4 · Immuneering Corp · Filed Jun 23, 2022
Insider Transaction Report
Form 4
Immuneering CorpIMRX
HAUSMAN DIANA
Director
Transactions
- Award
Stock Option
2022-06-21+6,185→ 6,185 totalExercise: $4.63Exp: 2032-06-20→ Class A Common Stock (6,185 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever comes first.